NP92624 (a-d) Enzyme Replacement Therapy Medicines
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £12M
- Sector
- HEALTH
- Published
- 02 Jul 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Aventis Pharma Reading
Description
Supply of Enzyme Replacement Therapy Medicines to NHS Scotland
Total Quantity or Scope
Supply of ERT Medicines to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.
Award Detail
| 1 | Aventis Pharma (Reading)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value of the Framework Agreements referred to in Sections II.1.7 and V.2.4 covers the twenty-four (24) month contract duration and the twelve (12) month extension period of the Framework Agreement. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=763554. (SC Ref:763554)
Reference
- FTS 020101-2024